Publications

April 18, 2023

Schlafender Hase Team

Reducing Medical Device Packaging Waste and Improving Information Provision Through E-Labelling

E-labelling offers patients and healthcare professionals the convenience of always having up-to-date information on their products, such as the latest safety updates. It also provides regulators with greater oversight and assurance that manufacturers are providing accurate and timely information. Dr. Jutta M. Hohenhörst, from Schlafender Hase, explores the benefits of e-labelling for the medical device sector and provides some practical tips for getting ahead with processes, procedures and solutions that deliver efficiencies and add value for patients.

3 minutes read

Reducing Medical Device Packaging Waste and Improving Information Provision Through E-Labelling

April 12, 2023

Schlafender Hase Team

E-labeling: The Road to Reduced Medical Device Packaging Material

New directives and guidance aim to connect patients, physicians and other stakeholders across the healthcare ecosystem with a consistently up-to-date information source for product and safety information that isn’t dependent on paper. Schlafender Hase’s Peter Muller explores the promise of e-labeling and practical next steps required to deliver on these directives.

5 minutes read

E-labeling: The Road to Reduced Medical Device Packaging Material

March 16, 2023

Schlafender Hase Team

Digital Transformation of Medical Device Labelling: A Practical Guide

By allowing medical device suppliers to provide up-to-date, reliable product and safety information in a secure and accessible format, e-labelling has the potential to revolutionise how medical professionals and patients access and manage information. In this article, Peter Muller of Schlafender Hase examines the potential of e-labelling and recommends practical steps to secure the benefits of e-labelling.

5 minutes read

Digital Transformation of Medical Device Labelling: A Practical Guide

November 2, 2022

Schlafender Hase Team

Change Management

As they try to plug the gaps, and hang on to the qualified and experienced experts they already have, life sciences companies need to be clever about how they support those people to make best use of the time, and how they alleviate the aspects of their job which add the least value professionally yet cannot be skimped on.

7 minutes read

Change Management

February 17, 2021

Schlafender Hase Team

The Devil in the Detail: 5 Routine Recall Risks Faced by Modern Pharma

With the steely eyes of the regulators firmly trained on everything that life sciences organisations do, the last thing firms want is to incur fines, market delays or worse because of overlooked mistakes in labelling and product information. Yet incidences of labelling issues and associated product recalls are rising sharply, now accounting for over 50% of all recalls according to the FDA. The conditions are rife for the trend to continue, due to growing complexity in life sciences firms’ operations and external market requirements.

6 minutes read

The Devil in the Detail: 5 Routine Recall Risks Faced by Modern Pharma

April 30, 2020

Schlafender Hase Team

The Leader in Intelligent Automated Proofreading Solutions

“Pharma labels are not just important for patients to learn about the specific formulations of a product, but also serve to identify, protect, and inform the patient on how to use them safely, and effectively,” says Regional Sales Director of Schlafender Hase, Marc Chaillou. At this juncture, one of the key challenges for pharma companies is aligning drug prescription instructions with regulatory requirements and additional language translations for a label.

3 minutes read

The Leader in Intelligent Automated Proofreading Solutions

January 29, 2019

Schlafender Hase Team

The Dangers of Leaving Packaging Quality to Chance

In this age of automation, it seems astounding that some fundamental tasks such as packaging and labelling quality checks are still handled manually to at least some degree. Yet this is the case even among some of the biggest pharmaceutical brands. That’s despite the high regulatory standards designed to protect patients, and the reputational risks and steep costs if errors slip through the net.

5 minutes read

The Dangers of Leaving Packaging Quality to Chance

October 20, 2017

Schlafender Hase Team

Adapt to Survive

No market is immune to change, and life sciences continues to face its fair share of upheaval as the industry accommodates emerging innovation in healthcare and a raft of other challenges to the status quo. Below are five of the most prominent trends and what they mean in practice.

5 minutes read

Adapt to Survive

September 27, 2017

Schlafender Hase Team

Form and Substance

One practical way to get ahead is to harness automation in the preparation of data by identifying and selecting the definitive source documents; checking for updates; and aligning languages, fonts and other intricacies. Sophisticated tools are available that reliably and precisely compare files in different formats for the possible information they contain. This ability to quickly contrast content of similar documents from multiple sources in large batches could help save firms vast amounts of time in this substantial preparatory stage of getting the company’s product data assets in order.

5 minutes read